Can I Take St. John's Wort with Tirosint?
At a glance
- Interaction class: generally avoided; classified by drug interaction databases as clinically significant, not merely theoretical
- Proposed mechanism: induction of hepatic and intestinal enzymes and P-glycoprotein, reducing effective levothyroxine exposure
- Formulation relevance: Tirosint's gel-cap design addresses absorption variability, not post-absorption clearance
- Monitoring: TSH and free T4 recommended after starting, stopping, or changing dose of an interacting supplement, per standard thyroid monitoring practice
- What is not established: the exact magnitude or onset timeline of TSH change caused specifically by St. John's Wort in levothyroxine users, since no dedicated trial has measured it directly
- Safer options for the mood/sleep indications people commonly use St. John's Wort for exist and should be discussed with a prescriber, not self-selected
The direct answer
St. John's Wort should not be started or continued alongside Tirosint without clinician input. This is not because a definitive trial has quantified the effect in hypothyroid patients, but because the plausible mechanism (enzyme and transporter induction that increases thyroid hormone clearance) is well established for other drugs metabolized through the same pathways, and because case reports describe thyroid hormone patients whose TSH rose while taking St. John's Wort. Tirosint's liquid gel-cap formulation, which improves and stabilizes absorption compared with some tablets, does not address this concern because the interaction happens after the hormone is already absorbed.
What Tirosint is, and why the formulation is relevant here
Tirosint is an FDA-approved levothyroxine sodium product supplied as a liquid-filled gel capsule. It contains fewer inactive fillers, dyes, and binders than many standard tablets, which is why it is sometimes prescribed for patients with malabsorption concerns, prior bariatric surgery, or lactose intolerance. Tirosint-SOL is a related liquid oral solution with a similar absorption profile.
The formulation difference matters for absorption-phase interactions, such as calcium, iron, or coffee interfering with tablet dissolution and gut uptake. It does not change what happens to levothyroxine once it has entered the bloodstream. After absorption, thyroid hormone clearance depends on deiodination, conjugation, biliary excretion, and enterohepatic recirculation involving intestinal transport proteins. Any agent that speeds up those downstream pathways can lower effective thyroid hormone exposure regardless of which levothyroxine product delivered the dose.
How St. John's Wort is thought to lower thyroid hormone levels
St. John's Wort contains hyperforin, a constituent known to activate the pregnane X receptor (PXR), a nuclear receptor that turns up expression of CYP3A4 and related metabolic enzymes as well as the drug efflux transporter P-glycoprotein (P-gp) in the liver and intestinal wall. This mechanism is well documented for other drugs, most notably reduced blood levels of oral contraceptives, cyclosporine, and certain antiretrovirals when taken with St. John's Wort.
For levothyroxine specifically, the proposed pathway is less about direct CYP3A4 metabolism (levothyroxine is not a classic CYP3A4 substrate) and more about P-gp upregulation in the gut, which can pump absorbed hormone back into the intestinal lumen and reduce reuptake during enterohepatic recirculation. This is a plausible, mechanistically coherent explanation, and it is consistent with case reports of rising thyroid-stimulating hormone (TSH) in patients on thyroid hormone replacement who started St. John's Wort. It has not been confirmed by a dedicated pharmacokinetic study measuring levothyroxine clearance directly in the presence of St. John's Wort, and readers should treat any specific percentage reduction in absorption or clearance as an estimate requiring verification rather than an established figure.
Why dose separation does not solve this
Many supplement-drug interactions with levothyroxine (calcium, iron, coffee, high-fiber meals) are absorption competitions at the gut lining, solved by spacing doses by three to four hours. Enzyme and transporter induction is a different kind of interaction: it is a systemic, days-to-weeks change in metabolic capacity, not a same-meal competition. Spacing St. John's Wort and Tirosint by a few hours would not meaningfully change CYP or P-gp expression. If a clinician decides the interaction risk is unacceptable, the practical resolution is stopping one of the two agents, not rescheduling doses.
What is established, what is plausible, and what is not established
| Question | Status | Basis |
|---|---|---|
| Does St. John's Wort induce CYP3A4, CYP2C9, CYP2C19, and P-glycoprotein through PXR activation? | Established | Well documented pharmacology, confirmed across multiple unrelated drug classes (oral contraceptives, cyclosporine, certain antiretrovirals) |
| Does that induction lower blood levels of many CYP3A4/P-gp substrate drugs? | Established | Extensively replicated for non-thyroid drugs |
| Does the same mechanism plausibly reduce effective levothyroxine exposure via reduced enterohepatic recirculation? | Plausible, mechanistically coherent | Extrapolated from P-gp pharmacology; not itself a levothyroxine-specific trial finding |
| Have case reports described TSH elevation in patients taking thyroid hormone with St. John's Wort? | Reported in the interaction literature | Case-level evidence; verify the specific report before citing a number or timeline |
| Is there a randomized controlled trial quantifying the effect of St. John's Wort on levothyroxine pharmacokinetics or TSH in hypothyroid patients? | Not established | No such trial was identified for this review |
| Does Tirosint's gel-cap formulation reduce this specific risk compared with tablets? | Not established, and mechanistically unlikely to matter | The interaction occurs after absorption, where formulation differences are no longer relevant |
| Is a precise onset timeline (for example, "TSH rises within 2-4 weeks") confirmed for this specific combination? | Not established as a fixed figure | Enzyme induction timelines of one to two weeks are described for other CYP3A4-inducing interactions generally; the exact levothyroxine timeline has not been directly measured in trials |
What a prescriber or pharmacist should verify before advising a patient: confirm the patient's current TSH/free T4 trend and levothyroxine indication (routine replacement versus cancer-suppression dosing), confirm the St. John's Wort product and dose being used (extracts vary in hyperforin content), and check whether the patient takes other CYP3A4 or P-gp substrate medications where induction risk is better characterized (oral contraceptives, anticoagulants, certain antidepressants).
Who carries the most risk if the interaction is real
Patients with no residual thyroid tissue, such as those post-thyroidectomy or after radioiodine ablation, depend entirely on their levothyroxine dose and have no buffering capacity if effective exposure drops. Patients on intentional TSH-suppression therapy after differentiated thyroid cancer treatment have less room for error, since even a modest reduction in effective dose could allow TSH to rise out of the suppressed target range with implications the treating oncologist or endocrinologist should weigh in directly.
Pregnancy is a separate and higher-priority concern. Thyroid hormone requirements increase during pregnancy, and levothyroxine dose adjustments during pregnancy should be managed by the treating clinician rather than inferred from a general guide. St. John's Wort also carries independent pregnancy safety concerns unrelated to thyroid function. Pregnant patients on Tirosint should not add St. John's Wort without discussing it with their obstetric or endocrine provider.
Symptoms that suggest the interaction may be happening
Returning hypothyroid symptoms, fatigue, cold intolerance, constipation, dry skin, weight gain, and cognitive slowing, are nonspecific and easy to attribute to stress, poor sleep, or the underlying mood condition someone was trying to treat with St. John's Wort in the first place. A normal TSH shortly after starting St. John's Wort does not rule out a later shift, since enzyme induction takes time to build.
If someone has already been taking both
- Stop the St. John's Wort. There is no established reason to taper it for this purpose; discuss with a clinician if it was being used to manage another condition that also needs a plan.
- Recheck TSH and free T4 after several weeks, not immediately. Enzyme induction and de-induction take time to resolve, so a lab drawn the day after stopping is unlikely to reflect the new steady state. Ask the ordering clinician what interval they recommend given the specific labs and dose history involved.
- Do not self-adjust the Tirosint dose. A dose change should follow lab confirmation, not symptom impression alone, since symptoms overlap heavily with mood and sleep conditions.
- Tell the prescriber about the supplement history, including product name, dose, and duration, at the next visit even if labs look normal in the interim.
Alternatives for the mood, anxiety, or sleep indications behind St. John's Wort use
Most people reach for St. John's Wort for mild depressive symptoms, anxiety, or sleep difficulty. Several options are commonly discussed as lower-interaction alternatives, though none should be self-selected as a substitute for a clinical evaluation of the underlying symptoms:
- Saffron extract (Crocus sativus). Some randomized trials report improvement in depressive symptom scores with saffron extract compared with placebo. It is not known to induce the same enzyme pathways as St. John's Wort, but a treating clinician should still confirm this fits the person's overall medication list.
- Omega-3 fatty acids (EPA-containing). Omega-3 supplementation has trial evidence in cardiovascular and some mood contexts and is not associated with thyroid hormone clearance interactions.
- Magnesium. Some small trials suggest a possible mood benefit from magnesium supplementation. Magnesium does interfere with levothyroxine absorption if taken at the same time, through direct binding in the gut, so it should be separated from Tirosint by at least four hours. This is a genuine dose-separation situation, unlike the St. John's Wort interaction, because the mechanism is local gut binding rather than systemic enzyme induction.
- Evidence-based psychotherapy, such as cognitive behavioral therapy, has no pharmacologic interaction with thyroid hormone and is a reasonable first discussion point with a prescriber for mild to moderate symptoms.
Any of these should be raised directly with the prescribing clinician rather than substituted independently, particularly if depressive symptoms are moderate to severe.
Where the record specifically needs review
This draft removes several precise figures that appeared in earlier reference material for this topic, including specific percentage changes in levothyroxine bioavailability, an exact TSH threshold and timeline, and quoted language attributed to a professional guideline and an interaction database. None of those could be verified against a confirmed primary source during this review, and a wrong citation is worse than no citation. Before publication, a reviewer should confirm current levothyroxine and Tirosint prescribing information for any listed herbal interaction language, and should pull the specific case report(s) describing thyroid hormone and St. John's Wort co-use to confirm the reported TSH change and timeline before citing a number.
When to seek urgent care rather than wait for a scheduled recheck
Severe hypothyroid symptoms, such as significant lethargy, confusion, marked cold intolerance, or signs of myxedema, warrant urgent medical evaluation rather than waiting for a routine follow-up lab. This is uncommon from a single supplement interaction but is more relevant in patients with little or no residual thyroid function.
Frequently asked questions
Can I take St. John's Wort while on Tirosint?
Does St. John's Wort interact with Tirosint?
Can I just take Tirosint and St. John's Wort at different times of day?
What should I do if I have already been taking both?
Does Tirosint's formulation reduce this risk compared with generic levothyroxine tablets?
What can I use instead of St. John's Wort for mood support while on Tirosint?
Does Tirosint-SOL (liquid) carry the same concern as the gel capsule?
References
This article is based on the known mechanisms by which St. John's Wort functions as a pregnane X receptor activator and inducer of CYP3A4 and P-glycoprotein, processes that have been established in research on other medications, as well as on standard clinical guidance for thyroid monitoring that calls for TSH and free T4 measurement following any modification to therapy that might alter how the body handles levothyroxine. During preparation of this article, specific numerical values regarding levothyroxine metabolism, particular TSH targets, and statements from clinical guidelines or drug databases were not confirmed through original research sources and therefore have either been excluded or made less definitive pending verification by editorial staff.
General reference: National Institutes of Health, Office of Dietary Supplements. https://ods.od.nih.gov/